Bellicum Pharmaceuticals, Inc.
Records under this name other than the patents Bellicum Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Back to Bellicum Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,434,935 | Modified Caspase Polypeptides and Uses Thereof In force · High confidence | In force | High confidence | |
| US 9,932,572 | Modified Caspase Polypeptides and Uses Thereof In force · High confidence | In force | High confidence | |
| US 9,944,690 | Methods for Controlling T Cell Proliferation In force · High confidence | In force | High confidence | |
| US 10,525,110 | Methods for Inducing Partial Apoptosis Using Caspase Polypeptides In force · Low confidence | In force | Low confidence | |
| US 11,839,647 | Methods for Inducing Partial Apoptosis Using Caspase Polypeptides In force · Medium confidence | In force | Medium confidence | |
| US 9,913,882 | Methods for Inducing Partial Apoptosis Using Caspase Polypeptides In force · High confidence | In force | High confidence | |
| US 10,888,608 | Costimulation of Chimeric Antigen Receptors by MYD88 and CD40 Polypeptides In force · High confidence | In force | High confidence | |
| US 10,918,705 | Costimulation of Chimeric Antigen Receptors by MYD88 and CD40 Polypeptides In force · High confidence | In force | High confidence | |
| US 10,934,346 | MODIFIED T CELL COMPRISING A POLYNUCLEOTIDE ENCODING AN INDUCIBLE STIMULATING MOLECULE COMPRISING MyD88, CD40 AND FKBP12 In force · High confidence | In force | High confidence | |
| US 12,410,231 | Natural Killer Cell Products and Methods In force · High confidence | In force | High confidence |